Controlled Substance Record-Keeping and Inventory Management
Controlled substance records and inventories must be maintained in conformance with State of Michigan and U.S. Department of Justice regulations. All documents related to controlled substances must be readily retrievable and available for immediate inspection (within 48 hours). Readily retrievable means that certain records are kept in such a manner that they can be separated out from all other records in a reasonable time and/or records are kept on which certain items are asterisked, redlined, or in some other manner visually identifiable apart from other items appearing on the records.
By law, inspections may be conducted by DEA Diversion Investigators, State of Michigan Bureau of Health Professions Investigators, and authorized police or law enforcement.
Records must be maintained for a period of two years from the last transaction date recorded. Five years is recommended.
All records must be stored in a secure location preferably locked in the cabinet or safe containing the controlled substances.
The following records must be maintained:
-
DEA Certificate of Registration 223 and State of Michigan controlled substances license
-
Authorized User List
-
Acquisition invoices for Schedule III-V controlled substances
-
DEA Form 222 for ordering Schedule I and II controlled substances
- Used, voided, and unused DEA 222 Forms must be maintained
-
Power of Attorney for DEA Form 222
-
Inventory records
- General inventory
- Initial inventory
- Annual inventory State of Michigan - A copy must be mailed each year
- Biennial inventory - DEA
-
Usage and administration records
-
Disposal records
-
Transfer records of controlled Substances transferred between registrants
-
DEA Form 106 - Report of Loss or Theft
Initial Inventory: An initial inventory for each licensed and registered location must be performed on the date the registrant first engages in any activity covered by their Michigan controlled substance research license and DEA researcher registration.
Initial Inventory Form
-
The initial inventory must include:
- Registrant's printed name
- DEA registration number and registration address
- Date and time (opening or closing of the day) inventory was performed
- Names of all controlled substances, dosage forms, dosage strengths, and quantities in possession of the registrant
- Initial inventories of zero must be documented
- The inventory form must be signed and dated by the registrant or authorized user and a witness
- Initial inventory records of Schedule I and Schedule II controlled substances must be kept separate from initial inventory records of Schedule III-V controlled substances
-
An inventory taken by use of an oral recording device must be promptly transcribed
-
The Registrant shall maintain the inventory in a written, typewritten, or printed form
-
An inventory will need to be taken for any new drug(s) or chemical(s), which were not previously listed in any schedule, that were added to a controlled substance schedule by the State of Michigan or the DEA. Afterwards, the substance(s) shall be accounted for on the normal State of Michigan annual inventory date for all controlled substances
Principal Investigators currently storing controlled substances acquired from ULAM in their laboratories must not include these agents as part of their initial inventory. These controlled substances are tracked under the ULAM controlled substance general inventory. Once a department or Principal Investigator acquires their DEA researcher registration number only those controlled substances obtained under their registration number can be placed in their general inventory. Initial inventories should be zero for new DEA researcher registrants.
The following options exist:
Annual Inventory: The State of Michigan requires an annual inventory of all controlled substances. The State of Michigan annual inventory must be performed between April 1st and June 30th of each year per Michigan Public Health Code, Section 333.7321.
Annual Inventory Form
-
The annual inventory must include the same information as the initial inventory
-
Annual inventory records of Schedule I and Schedule II controlled substances must be kept and reported separately from annual inventory records of Schedule III-V controlled substances.
Annual inventories must be mailed to the following address per Michigan law:
State of Michigan
Bureau of Health Professions
Health and Regulatory Division, Annual Inventory
6546 Mercantile Way, Suite 2
PO BOX 30454
Lansing, MI 48909
For questions regarding annual inventory requirements, contact the Michigan Bureau of Health Professions-Investigation Division at: (517) 373-1737 or bhpinfo@michigan.gov.
Biennial Inventory: The DEA requires a physical inventory of all controlled substances to be conducted every two years. The inventory may be taken on any date within two years of the previous inventory date. A copy of the State of Michigan annual inventory will satisfy this requirement. The biennial inventory is maintained at the registrant’s location for two years and is not sent to the DEA.
Perpetual or General Inventory: An ongoing current or perpetual inventory is required to track acquisitions, administration, transfers to usage logs, transfers to other registrants, and disposals of controlled substances.
General Inventory Log
-
A separate general inventory log should be created for each stock of drug and its associated strength or container size
-
Controlled substance containers should be transferred from the general inventory log to usage logs for tracking doses delivered from the same container
-
Individual vials or containers should be assigned a unique (non-reusable) number or code (date + vial number or other identifier) upon receipt by the registrant to assist with tracking
-
Controlled substances should remain in their original packaging. Compounded controlled substances should be labeled accordingly if purchased from a vendor or compounding pharmacy
-
General inventory records of Schedule I and II controlled substances must be kept separate from general inventory records of Schedule III-V controlled substances
-
Registrants may develop their own inventory forms provided a controlled substance can be tracked from acquisition to research subject or experimental endpoint
Usage Logs: Controlled substances must be tracked from acquisition to administration (to a research subject or usage in an in-vitro or chemical process). It is recommended to keep all usage logs in a standard binder.